HPE to Acquire Juniper Networks to Accelerate AI-Driven Innovation
HOUSTON & SUNNYVALE, Calif.--(BUSINESS WIRE)--Jan 9, 2024--
Source: eagletribune.com
📰 Initial Statements News
Page 3 - Initial Statements News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Initial Statements. Real-time updates on events, politics, business and more.
HPE to Acquire Juniper Networks to Accelerate AI-Driven Innovation
Highly complementary combination enhances secure, unified, cloud and AI-native networking to drive innovation from edge to cloud to exascale Accelerates long-term revenue growth and expands gross...
Source: marketscreener.com
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
Portfolio of Clinical and Preclinical Programs, Including Lead Product Candidate ARX517, a Prostate-Specific Membrane Antigen -Targeting Antibody Drug Conjugate , Strengthens Johnson & Johnsons...
Yusri Elsayed Margaret Yu Johnson The Company Scripps Research Institute Ambrx Biopharma Inc Exchange Commission
Source: marketscreener.com
FG Financial Group, Inc. and FG Group Holdings Inc. Sign
Combined Company to Benefit from Anticipated Significant Expense Savings, Improved Scale and Capital Efficiency Represents Over $110 Million in...
Source: globenewswire.com
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
Transaction Delivers KarXT, a First-in-Class M1 / M4 Muscarinic Receptor Agonist, with Differentiated Efficacy and Safety KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an...
Christopher Boerner Bristol Myers Squibb Samit Hirawat Bristol Myer Squibb Securities Exchange Covington Burling
Source: marketscreener.com
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
Transaction Delivers KarXT, a First-in-Class M1 / M4 Muscarinic Receptor Agonist, with Differentiated Efficacy and Safety KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an...
Christopher Boerner Bristol Myer Squibb Samit Hirawat Bristol Myers Squibb Gordon Dyal Co Karuna Therapeutics Inc
Source: marketscreener.com
Consolidated Communications Files Letter to Shareholders Highlighting Benefits of Proposed Transaction with Searchlight and BCI
Files Definitive Proxy Urges Shareholders to Protect Their Investments by Voting FOR the Proposed Transaction ...
United Kingdom Cable One Charter Communications British Columbia Investment Management Corporation Wildcat Capital Management Company Annual Report On Form
Source: marketscreener.com
Consolidated Communications Announces Third Quarter Financial Results
Consolidated Communications Holdings, Inc. , a top 10 fiber provider in the U.S., today reported results for the third quarter of 2023. Third Quarter 2023 Results Revenue totaled $283.7...
United States Kansas City United Kingdom British Columbia Investment Management Corporation Condor Holdings Service Funds
Source: marketscreener.com
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
Highlights AIM’s Significant Momentum and Ongoing Achievement of Clinical and Regulatory Milestones Urges Shareholders to Protect AIM’s Progress by Voting for the Company’s Board of Directors...
Source: marketscreener.com
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced financial results for the third quarter...
City Of United Kingdom Charles Baum Myers Squibb Committee For Medicinal Products Human Use Mirati Therapeutics Inc
Source: prnewswire.com